Thus, it is very necessary to conduct a comprehensive analysis of the expression of all Ms in GBM, including TME ICs infiltration, stemness, and novel immunotherapy, which will provide new theoretical support for subsequent biological studies. The gene discussed is MTR; the disease is glioblastoma.